TERAPIA CELULAR, CÉLULAS MADRE Y TEJIDOS
Universitat d'Alacant
Alicante, EspañaPublikationen in Zusammenarbeit mit Forschern von Universitat d'Alacant (3)
2023
-
Rationale for combined therapies in severe-to-critical COVID-19 patients
Frontiers in Immunology, Vol. 14
2021
-
A phase I/II dose-escalation multi-center study to evaluate the safety of infusion of natural killer cells or memory T cells as adoptive therapy in coronavirus pneumonia and/or lymphopenia: RELEASE study protocol
Trials, Vol. 22, Núm. 1
-
Phase I dose-escalation single centre clinical trial to evaluate the safety of infusion of memory T cells as adoptive therapy in COVID-19 (RELEASE)
EClinicalMedicine, Vol. 39